Journal ArticleOPEN ACCESS

Adjuvant Therapy-Related Shortening of Survival (ATRESS): An Underrated Phenomenon

  • Fink M
  • Kleeberg U
  • Bartels S
The Oncologist (2015) 20(1) 88-88
DOI: 10.1634/theoncologist.2014-0273
20Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Shortening of survival after dissemination following adjuvant treatment is not understood well enough and is difficult to search for in public databases because of the lack of specific search terms. We suggest using the acronym ATRESS, for “adjuvant therapy-related shortening of survival,” in future literature concerning this issue.

Cite

CITATION STYLE

APA

Fink, M. K., Kleeberg, U. R., & Bartels, S. (2015). Adjuvant Therapy-Related Shortening of Survival (ATRESS): An Underrated Phenomenon. The Oncologist, 20(1), 88–88. https://doi.org/10.1634/theoncologist.2014-0273

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free